Last reviewed · How we verify
EVARREST® Fibrin Sealant Patch — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
EVARREST® Fibrin Sealant Patch (EVARREST® Fibrin Sealant Patch) — Ethicon, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| EVARREST® Fibrin Sealant Patch TARGET | EVARREST® Fibrin Sealant Patch | Ethicon, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- EVARREST® Fibrin Sealant Patch CI watch — RSS
- EVARREST® Fibrin Sealant Patch CI watch — Atom
- EVARREST® Fibrin Sealant Patch CI watch — JSON
- EVARREST® Fibrin Sealant Patch alone — RSS
Cite this brief
Drug Landscape (2026). EVARREST® Fibrin Sealant Patch — Competitive Intelligence Brief. https://druglandscape.com/ci/evarrest-fibrin-sealant-patch. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab